Fund Holdings — Rosalind Advisors, Inc.

Total Portfolio Value
$206.65M
Total Bought
$44.46M
Total Sold
$38.57M
Net Transaction
+$5.89M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CYTOKINETICS INC(CYTK)0400,000+400,000013,2166.40%+13,216
REZOLUTE INC(RZLT)01,741,211+1,741,21107,7663.76%+7,766
FENNEC PHARMACEUTICALS INC(FENC)1,782,8442,045,644+262,80010,85816,9798.22%+6,121
CG ONCOLOGY INC(CGON)0192,974+192,97405,0172.43%+5,017
DELCATH SYS INC(DCTH)2,900,3893,300,389+400,00029,00433,00415.97%+4,000
VERONA PHARMA PLC100,000100,00006,3499,4584.58%+3,109
OCULAR THERAPEUTIX INC(OCUL)1,218,7001,218,70008,93311,3105.47%+2,376
VIRIDIAN THERAPEUTICS INC(VRDN)595,000700,000+105,0008,0219,7864.74%+1,765
CYBIN INC(HELP)810,918810,91805,1416,8043.29%+1,662
POLYPID LTD(PYPD)1,018,021975,462-42,5592,7593,4431.67%+685
PHARVARIS N V
COM
223,627223,62703,5113,9361.90%+425
MIND MEDICINE MINDMED INC420,000420,00002,4572,7261.32%+269
BIOFRONTERA INC(BFRI)644,393976,448+332,0555166950.34%+179
OVID THERAPEUTICS INC(OVID)0500,000+500,00001650.08%+165
REPLIMUNE GROUP INC(REPL)850,000900,000+50,0008,2888,3614.05%+74
PROFOUND MED CORP(PROF)692,185692,18504,0294,0841.98%+55
MEDIWOUND LTD(MDWD)506,893407,061-99,8327,8677,8853.82%+18
TALPHERA INC(TLPH)2,003,9392,003,93909929220.45%-70
KURA ONCOLOGY INC(KURA)100,000100,00006605770.28%-83
ALPHA COGNITION INC(ACOG)104,8360-104,8365300—-530
IDEAYA BIOSCIENCES INC(IDYA)700,000511,132-188,86811,46610,7445.20%-722
KIORA PHARMACEUTICALS INC(KPRX)250,0590-250,0597530—-753
INSPIREMD INC(NSPR)2,274,9902,289,099+14,1096,1205,1962.51%-923
COMPASS PATHWAYS PLC(CMPS)823,286482,651-340,6352,3551,3510.65%-1,003
SAVARA INC(SVRA)2,654,9442,654,94407,3546,0532.93%-1,301
COGENT BIOSCIENCES INC(COGT)248,2850-248,2851,4870—-1,487
KALVISTA PHARMACEUTICALS INC303,864157,725-146,1393,5071,7830.86%-1,724
TREVI THERAPEUTICS INC(TRVI)612,901300,000-312,9013,8551,6410.79%-2,214
OPTINOSE INC256,1900-256,1902,3490—-2,349
UROGEN PHARMA LTD(URGN)950,000542,366-407,63410,5077,4303.60%-3,077
XERIS BIOPHARMA HOLDINGS INC2,495,9862,155,594-340,39213,70310,0674.87%-3,636
NUVATION BIO INC(NUVB)2,451,5000-2,451,5004,3150—-4,315
MYOMO INC(MYO)2,703,6613,595,788+892,12713,0057,7673.76%-5,238
VERASTEM INC(VSTM)2,644,5172,043,563-600,95415,9468,4814.10%-7,466
ABEONA THERAPEUTICS INC(ABEO)1,805,8170-1,805,8178,5960—-8,596
Page 1 of 1
Rosalind Advisors, Inc. — 13F Holdings — Q2 2025 | TickerTrail